Abstract
We address here the effects of increasing fluencies of UV-radiation on stability, modifications, activity and HDM2-interactions of endogenous p53 tumor suppressor and on cellular damage response of human diploid fibroblasts. Low amounts of UVB/C-radiation induced a transient cell cycle arrest of the cells which correlated with rapid but transient increase in p53 levels. In contrast, high UV-fluency caused cell apoptosis and a slower but sustained increase in p53. Regulation of p53 target genes was highly dependent on the radiation dose used. Whereas low doses induced p21/Cip1/Waf1 and HDM2, high doses induced only GADD45 and BAX increasing the BAX:BCL-2 ratio. The levels of HDM2, a negative regulator of p53, increased only by the low dose of UVC and p53-HDM2 association was promoted. In the absence of HDM2-induction after the high dose of UV-radiation p53-HDM2-interaction was promoted, but HDM2 failed to downregulate p53. p53 site-specific modifications (Ser15, Ser33, Ser37, Lys382) varied kinetically and were dependent on the fluency of the radiation used. Maximal phosphorylation of p53 on Ser15 and Ser33 correlated with increased levels of HDM2-free p53. The results suggest that regulation of p53 and HDM2 by UV-radiation is highly dose-dependent and contributes to the outcome of the cellular response.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrews NC, Faller DV . 1991 Nucleic Acids Res. 19: 2499
Ashcroft M, Kubbutat MHG, Vousden KH . 1999 Mol. Cell. Biol. 19: 1751–1758
Blattner C, Tobiash E, Liften M, Rahmsdorf HJ, Herrlich P . 1999 Oncogene 18: 1723–1732
Barak Y, Juven T, Haffner R, Oren M . 1993 EMBO J. 12: 461–468
Barley RDC, Enns L, Paterson MC, Mirzayans R . 1998 Oncogene 17: 533–543
Buschmann T, Adler V, Matusevich E, Fuchs SY, Ronai Z . 2000 Cancer Res. 60: 896–900
Chang D, Chen F, Zhang F, McKay B, Ljungman M . 1999 Cell Growth Differ. 10: 155–162
Chao C, Saito S, Anderson CW, Appella E, Xu Y . 2000 Proc. Natl. Acad. Sci. USA 97: 11936–11941
Chen J, Marechal V, Levine AJ . 1993 Mol. Cell Biol. 13: 4107–4114
Chomczynski P . 1992 Anal. Biochem. 201: 134–139
Craig AL, Burch L, Vojtesek B, Mikutowska J, Thompson A, Hupp TR . 1999 Biochem. J. 342: 133–141
Dumaz N, Meek DW . 1999 EMBO J. 18: 7002–7010
El-Deiry WS . 1998 Semin. Cancer Biol. 8: 345–357
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825
Gu W, Roeder RG . 1997 Cell 90: 595–606
Haapajärvi T, Pitkänen K, Tsubari M, Laiho M . 1997 Mol. Cell. Biol. 17: 3074–3080
Haapajärvi T, Kivinen L, Heiskanen A, des Bordes C, Datto MB, Wang X-F, Laiho M . 1999 Exp. Cell Res. 248: 272–279
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . 1993 Cell 75: 805–816
Haupt Y, Maya R, Kazaz A, Oren M . 1997 Nature 387: 296–299
Honda R, Tanaka H, Yasuda H . 1997 FEBS Lett. 420: 25–27
Honda R, Yasuda H . 1999 EMBO J. 18: 22–27
Juven T, Barak Y, Zauberman A, George DL, Oren M . 1993 Oncogene 8: 3411–3416
Kapoor M, Hamm R, Yan W, Taya Y, Lozano G . 2000 Oncogene 19: 358–364
Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace Jr AJ . 1992 Cell 71: 587–597
Kubbutat MHG, Jones SN, Vousden KH . 1997 Nature 387: 299–303
Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN . 1998 J. Biol. Chem. 273: 33048–33053
Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ, Oren M . 2000 Proc. Natl. Acad. Sci. USA 97: 11250–11255
Levine AJ . 1997 Cell 88: 323–331
Ljungman M, Zhang F, Chen F, Rainbow AJ, McKay B . 1999 Oncogene 18: 583–592
Loignon M, Fetni R, Gordon AJE, Drobetsky EA . 1997 Cancer Res. 57: 3390–3394
Lu X, Burbidge SA, Griffin S, Smith HM . 1996 Oncogene 13: 413–418
Mailand N, Falck J, Lukas C, Syljuåsen RG, Welcker M, Bartek J, Lukas J . 2000 Science 288: 1425–1429
Maki CG, Huibregtse JM, Howley PM . 1996 Cancer Res. 56: 2649–2654
Maltzman W, Czyzyk L . 1984 Mol. Cell. Biol. 9: 1689–1694
McKay BC, Ljungman M, Rainbow AJ . 1998 Oncogene 17: 545–555
Meek DW . 1999 Oncogene 18: 7666–7675
Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC . 1994 Oncogene 9: 1799–1805
Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y . 2000 Cell 102: 849–862
Perry ME, Piette J, Zawadzki JA, Harvey D, Levine AJ . 1993 Proc. Natl. Acad. Sci. 90: 11623–11627
Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . 1997 Nature 305
Reinke V, Lozano G . 1997 Rad. Res. 148: 115–122
Rodriquez MS, Desterro JMP, Lain S, Lane DP, Hay RT . 2000 Mol. Cell. Biol. 20: 8458–8467
Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E . 1998 Genes Dev. 12: 2831–2841
Saucedo LJ, Carstens BP, Seavey SE, Albee II LD, Perry ME . 1998 Cell Growth Differ. 9: 119–130
Shieh S-Y, Ikeda M, Taya Y, Prives C . 1997 Cell 91: 325–334
Shieh S-Y, Taya Y, Prives C . 1999 EMBO J. 18: 1815–1823
Shieh S-Y, Ahn J, Tamai K, Taya Y, Prives C . 2000 Genes Dev. 14: 289–300
Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB . 1997 Genes Dev. 11: 3471–3481
Thomas A, White E . 1998 Genes Dev. 12: 1975–1985
Tyrrell RM . 1994 Mol. Asp. Med. 15: 3–77
Unger T, Juven-Gershon T, Moallem E, Berger M, Sionov RV, Lozano G, Oren M, Haupt Y . 1999 EMBO J. 18: 1805–1814
Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Freidberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K, Harris CC . 1995 Nat. Genet. 10: 188–195
Wu L, Levine A . 1997 Mol. Med. 3: 441–451
Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ . 2000 Genes Dev. 14: 981–993
Acknowledgements
Annamari Heiskanen is thanked for excellent technical assistance. We thank Leif Andersson for PARP antibody and Toivo Maimets for 2A10 antibody. This study was supported by the Academy of Finland, Centre of Excellence Program (grant no 44895), Biocentrum Helsinki, the Finnish Cancer Organization and the Ida Montin Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Latonen, L., Taya, Y. & Laiho, M. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts. Oncogene 20, 6784–6793 (2001). https://doi.org/10.1038/sj.onc.1204883
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204883
Keywords
This article is cited by
-
Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program
Cell Death & Differentiation (2023)
-
Single loss of a Trp53 allele triggers an increased oxidative, DNA damage and cytokine inflammatory responses through deregulation of IκBα expression
Cell Death & Disease (2021)
-
Human mesenchymal stem cells are resistant to UV-B irradiation
Scientific Reports (2019)
-
Preservation effects of geniposidic acid on human keratinocytes (HaCaT) against UVB
Biomedical Dermatology (2018)
-
Unexpected dose response of HaCaT to UVB irradiation
In Vitro Cellular & Developmental Biology - Animal (2018)